Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$34.4M |
| 2 |
LM
Legg Mason, Inc.
LM
|
+$15.7M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$12.8M |
| 4 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$12M |
| 5 |
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
|
+$8.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.5M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$28.2M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$27M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$21M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 16.96% |
| 3 | Financials | 14.62% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Penumbra
PEN
$12.8B
| – | – |
-3,025
| Closed | -$497K |
|
1252
PetMed Express
PETS
$38.2M
| – | – |
-51,880
| Closed | -$1.22M |
|
1253
Pfizer
PFE
$160B
| – | – |
-166,195
| Closed | -$6.18M |
|
1254
Performance Food Group
PFGC
$16.5B
| – | – |
-10,016
| Closed | -$516K |
|
|
PGRE
1255
DELISTED
Paramount Group
PGRE
| – | – |
-136,823
| Closed | -$1.91M |
|
1256
Phreesia
PHR
$749M
| – | – |
-27,685
| Closed | -$738K |
|
1257
Photronics
PLAB
$1.8B
| – | – |
-29,137
| Closed | -$459K |
|
1258
Children's Place
PLCE
$55.4M
| – | – |
-14,659
| Closed | -$916K |
|
1259
Palomar
PLMR
$3.42B
| – | – |
-7,078
| Closed | -$357K |
|
1260
ePlus
PLUS
$2.27B
| – | – |
-13,736
| Closed | -$579K |
|
1261
Philip Morris
PM
$293B
| – | – |
-43,900
| Closed | -$3.73M |
|
1262
Pinnacle West Capital
PNW
$11.8B
| – | – |
-2,272
| Closed | -$204K |
|
1263
Post Holdings
POST
$3.65B
| – | – |
-25,838
| Closed | -$1.84M |
|
|
PRA
1264
DELISTED
ProAssurance
PRA
| – | – |
-8,784
| Closed | -$317K |
|
|
P
1265
Everpure Inc
P
$36.1B
| – | – |
-20,907
| Closed | -$358K |
|
1266
Patterson-UTI
PTEN
$4.71B
| – | – |
-74,648
| Closed | -$784K |
|
1267
Quanta Services
PWR
$96.1B
| – | – |
-27,236
| Closed | -$1.11M |
|
1268
Qiagen
QGEN
$9.1B
| – | – |
-59,066
| Closed | -$2.12M |
|
1269
Qualys
QLYS
$6.3B
| – | – |
-23,364
| Closed | -$1.95M |
|
1270
RBC Bearings
RBC
$16B
| – | – |
-1,643
| Closed | -$260K |
|
1271
Royal Caribbean
RCL
$78.1B
| – | – |
-18,713
| Closed | -$2.5M |
|
1272
Arcus Biosciences
RCUS
$3.86B
| – | – |
-13,423
| Closed | -$136K |
|
|
RDFN
1273
DELISTED
Redfin
RDFN
| – | – |
-79,362
| Closed | -$1.68M |
|
|
RDUS
1274
DELISTED
Radius Recycling
RDUS
| – | – |
-17,001
| Closed | -$369K |
|
1275
Radware
RDWR
$1.17B
| – | – |
-15,664
| Closed | -$404K |
|
Similar funds
Paul Tudor Jones's Q1 2020 Portfolio in Review
As of Q1 2020, Paul Tudor Jones held 1,500 positions worth $1.12B, down 50% from $2.23B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Paul Tudor Jones withdrew a net $741M in Q1 2020, closing 486 positions and reducing 367 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Paul Tudor Jones opened a new position in GCI Liberty, Inc. Class A Common Stock (DE) worth $7.42M.
- Paul Tudor Jones's largest Q1 2020 buy was GCI Liberty, Inc. Class A Common Stock (DE): 130,150 shares worth $7.42M.
- Paul Tudor Jones added most to RTX Corp in Q1 2020, an estimated $34.4M increase.
- Paul Tudor Jones's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $44.5M.
- Paul Tudor Jones fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $27M.
- Paul Tudor Jones's ten largest holdings make up 28% of its $1.12B portfolio in Q1 2020.
- Paul Tudor Jones opened 388 new positions and closed 486 in Q1 2020.
- Paul Tudor Jones's portfolio value fell 50% quarter-over-quarter to $1.12B.
Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.